Private Label Tranexamic Acid Kojic Acid Underarm Cream

What regulatory approvals or certifications do I need before selling private label tranexamic acid and kojic acid underarm cream?

By Blake Mereby · Last reviewed October 5, 2026

Regulatory requirements for selling private label tranexamic acid and kojic acid underarm cream vary significantly by country and depend on whether you're making a cosmetic claim (brightening, evening tone) or a drug claim (treating melasma, reducing hyperpigmentation as a medical condition). In the US, the product is classified as a cosmetic if it merely cleanses, beautifies, or improves appearance; it becomes a drug if you claim it treats, prevents, cures, or mitigates disease or abnormal conditions. In the US, cosmetics require no pre-market approval—you simply ensure ingredient safety and comply with labeling rules—but drugs require clinical data and an IND (Investigational New Drug) application or a New Drug Application (NDA), adding 12–36 months and significant cost. The vast majority of indie underarm creams position themselves as cosmetics, not drugs, by using careful language on labels and in marketing ("brightens the appearance" vs. "treats dark spots"). Before your formulation is finalized, consult a regulatory specialist or cosmetic attorney to confirm your claims stay within the cosmetic box; a misclassified claim can result in warning letters from the FDA, product seizure, or fines.

In the United States (FDA), your responsibilities as a cosmetic manufacturer or brand are: (1) Register your facility with the FDA (if you own the manufacturing facility) or work with a registered co-packer. (2) Ensure all ingredients are on the FDA's "Cosmetic Ingredient Dictionary" or are recognized as safe for cosmetics. Tranexamic acid and kojic acid are both listed and permissible. (3) Maintain a batch record and ingredient list for each SKU. (4) Declare all ingredients on the product label in the order of descending concentration (INCI nomenclature), using terms from the INCI Dictionary. (5) Include a warning label if the product is intended for children under 12 or has any risk of eye contact (though an underarm cream is low-risk here). (6) List allergens such as tree nuts or sesame if they're in the formulation. (7) Include your company name and address on the label. (8) Store records for at least three years and produce them on FDA request. Your co-packer typically handles batch record generation and ensures INCI compliance; you are responsible for label copy, ingredient order, and claims. Do not require clinical testing for a cosmetic claim, but the FDA can request substantiation if a claim seems exaggerated; having stability data and in-vitro efficacy studies (e.g., melanin inhibition assays) on file is prudent.

In the European Union, underarm creams containing tranexamic acid and kojic acid are regulated under the EC Cosmetics Regulation (EC 1223/2009). Before sale, you must: (1) Create a Safety Assessment File (SAF) or Product Information File (PIF) that documents the formula's safety based on ingredient toxicology, concentration, pH, preservative efficacy (microbial challenge testing per ISO 11930), and stability data. (2) Verify that every ingredient is compliant with Annex III (banned/restricted substances), Annex IV (permitted colorants), and Annex V (permitted UV filters). Tranexamic acid is not restricted; kojic acid is not restricted, but some derived dyes (e.g., Acid Red, if present as an impurity) may be. (3) Notify the CPNP (Cosmetics Products Notification Portal) with your formula, facilities, and responsible person information before placing the product on the market; no approval is required, but registration is mandatory. (4) Have a responsible person (a legal entity or individual based in the EU) who oversees compliance. (5) Comply with labeling requirements: ingredient declaration in INCI, warning statements, net weight, name and address of responsible person, shelf-life or period-after-opening (PAO) symbol (e.g., "12M" for 12 months). (6) If claiming to be hypoallergenic or dermatologist-tested, back these up with documentation. The EU does not require pre-market efficacy testing for cosmetics, but you must substantiate any claims with data; a simple stability protocol and safety assessment are sufficient to comply.

In China (NMPA), the regulatory pathway has become stricter in recent years. Imported cosmetics (including private label) must be registered with the NMPA before sale. The process involves: (1) Appointing a local Chinese entity or agent to act as your importer of record. (2) Submitting the formula, safety data, and manufacturing facility registration to the NMPA. (3) Awaiting NMPA review and approval, which typically takes 4–8 weeks for standard cosmetics (no clinical testing required). (4) Complying with Chinese labeling: Chinese language ingredient declaration, warnings, usage instructions, importer/manufacturer contact info. (5) Tranexamic acid and kojic acid are both permissible in China; they do not appear on restricted lists. (6) If making brightening or whitening claims, the NMPA scrutinizes the language; claims must not imply efficacy equivalent to a drug. Working with a Chinese co-packer or an import agent who understands NMPA filing is essential because procedural delays or incomplete submissions can stall your launch by weeks. Do not ship product to China for sale before NMPA approval; if caught, product is seized.

In Australia (TGA), cosmetics follow the Australian Consumer Law and TGA's Therapeutic Goods Administration rules. Tranexamic acid and kojic acid are permissible in cosmetic products. Before selling, you must: (1) Ensure the formula meets the Australian Safety Standards. (2) Declare ingredients in English using INCI nomenclature on the label, plus the product name, net quantity, directions for use, and any warnings (e.g., "Avoid eye contact"). (3) Include the name and address of the responsible person (manufacturer or local distributor). (4) If claiming therapeutic benefit (treating melasma, etc.), the product is reclassified as a Therapeutic Good and requires TGA approval, clinical data, and registration—do not make therapeutic claims unless prepared for this pathway. (5) If you're claiming brightening or toning (cosmetic claims), no pre-approval is needed, but TGA can audit your substantiation post-market. The TGA does not require pre-market registration for cosmetics, but marketing claims must be truthful and substantiated.

Canada (Health Canada) follows the Natural and Non-prescription Health Products Directorate (NNHPD) for cosmetics. Tranexamic acid and kojic acid are permissible. Before sale: (1) Ensure all ingredients comply with the Canadian Cosmetics Regulations. (2) Label in both English and French, including ingredient declaration, net quantity, directions, warnings, and manufacturer/distributor contact info. (3) If claiming to treat a disease or abnormal condition, the product crosses into "Natural Health Product" or "Drug" territory and requires licensing and clinical evidence; avoid such claims. (4) No pre-market approval is required for cosmetics, but Health Canada can demand substantiation post-market.

Key compliance steps across all markets: (1) Micro-batch stability testing (4–8 weeks at 40°C/75% RH, plus room temperature baseline) to confirm tranexamic acid and kojic acid remain potent and the formula is microbiologically safe. (2) Microbial challenge testing per ISO 11930 (or equivalent) to validate your preservative system prevents mold, bacteria, and yeast growth. (3) pH and viscosity stability over 12 months at room temperature. (4) INCI ingredient nomenclature compliance (e.g., "Tranexamic Acid," "Kojic Acid" or "Dipalmitoly Kojic Acid"). (5) Written claim substantiation (if you say "brightens," have data supporting that claim—efficacy studies, consumer trials, or literature). (6) Label copy reviewed by a regulatory specialist before printing. (7) Batch records with formula, material lots, manufacturing date, QA results, and expiration date.

Common mistakes: (1) Launching without confirming your claims are cosmetic, not drug-level. A single phrase ("treats," "cures," "heals") can trigger FDA enforcement. (2) Skipping microbial challenge testing and then discovering your product supports mold growth mid-shelf-life. (3) Assuming a formulation legal in one market (e.g., US) is legal everywhere; regulations differ, especially in China and Australia. (4) Not translating labels and safety files into local languages where required (China, Canada, Quebec). On the AJ Cosmo Labs platform, your assigned co-packer and regulatory resources can guide you through market-specific requirements; some co-packers offer compliance consultation as a service, bundling regulatory review with manufacturing. Investing in upfront compliance avoids costly recalls, seized inventory, or rebranding later.

Ingredients in this answer: Tranexamic Acid · Kojic Acid

Read the full guide on Private Label Tranexamic Acid Kojic Acid Underarm Cream →

More about Private Label Tranexamic Acid Kojic Acid Underarm Cream

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app